Holleschau A M, Rathbun W B, Nagasawa H T
Department of Ophthalmology, University of Minnesota, Minneapolis 55455, USA.
Curr Eye Res. 1996 May;15(5):501-10. doi: 10.3109/02713689609000761.
To apply a high performance liquid chromatographic radiotracer method to test a variety of L-cysteine prodrugs and one dipeptide prodrug for their ability to synthesize glutathione in cultured rat lenses.
Rat lenses were incubated for 48 h in a medium containing [14C(U)]-glycine and prodrugs. Following homogenization and derivatization, lens extracts were analyzed to determine the extent of biosynthetic incorporation of this labeled amino acid into [14C]-glutathione using high performance liquid chromatography with radioisotope and ultraviolet absorption detection. All of the thiazolidine prodrugs contained masked sulfhydryl groups to stabilize them against air oxidation. L-buthionine-(S,R)-sulfoximine-an inhibitor of the first step in glutathione biosynthesis-was present in media containing the dipeptide prodrug.
In all cases, a large [14C]-labeled peak eluted just prior to [14C]-glutathione. This peak had some characteristics of the mixed disulfide of glutathione and L-cysteine, viz., L-cysteine/glutathione disulfide, but requires further investigation in order to be positively identified. Of the eleven L-cysteine prodrugs investigated, the most effective was 2(R,S)-methylthiazolidine-4(R)-carboxylic acid, which increased the rate of [14C]-glutathione biosynthesis 35% over that of the controls. A number of other L-cysteine prodrugs were somewhat effective, increasing glutathione synthesis 5-30% over the controls, while several L-cysteine prodrugs were totally ineffective. The only dipeptide prodrug investigated, viz., gamma-L-glutamyl-L-cysteine ethyl ester, increased the biosynthesis of [14C]-glutathione 18% over control. Biosynthetic rates based on ultraviolet absorption of the derivatized glutathione demonstrated a similar pattern, the compounds most effective in synthesizing [14C]-glutathione generally yielding the highest ultraviolet glutathione concentrations and the ineffective compounds showing the lowest concentrations.
2(R,S)-methylthiazolidine-4(R)-carboxylic acid, 2(R,S)-n-propylthiazolidine-4(R)-carboxylic acid and N-acetyl-L-cysteine were the only compounds that were statistically significant in yielding higher levels of both ultraviolet and radioactive glutathione as compared to their respective controls. Thus, these prodrugs have very promising anti-cataract potential.
应用高效液相色谱放射性示踪法检测多种L-半胱氨酸前体药物和一种二肽前体药物在培养的大鼠晶状体中合成谷胱甘肽的能力。
将大鼠晶状体在含有[14C(U)]-甘氨酸和前体药物的培养基中孵育48小时。匀浆和衍生化后,使用具有放射性同位素和紫外吸收检测功能的高效液相色谱分析晶状体提取物,以确定这种标记氨基酸生物合成掺入[14C]-谷胱甘肽的程度。所有噻唑烷前体药物都含有被掩盖的巯基,以使其免受空气氧化。在含有二肽前体药物的培养基中存在L-丁硫氨酸-(S,R)-亚砜亚胺——谷胱甘肽生物合成第一步的抑制剂。
在所有情况下,一个大的[14C]标记峰在[14C]-谷胱甘肽之前洗脱。该峰具有谷胱甘肽和L-半胱氨酸混合二硫键的一些特征,即L-半胱氨酸/谷胱甘肽二硫键,但需要进一步研究才能确定。在所研究的11种L-半胱氨酸前体药物中,最有效的是2(R,S)-甲基噻唑烷-4(R)-羧酸,其[14C]-谷胱甘肽生物合成速率比对照组提高了35%。许多其他L-半胱氨酸前体药物有一定效果,谷胱甘肽合成比对照组增加了5-30%,而几种L-半胱氨酸前体药物完全无效。所研究的唯一二肽前体药物,即γ-L-谷氨酰-L-半胱氨酸乙酯,其[14C]-谷胱甘肽的生物合成比对照组增加了18%。基于衍生化谷胱甘肽紫外吸收的生物合成速率呈现出类似的模式,在合成[14C]-谷胱甘肽方面最有效的化合物通常产生最高的紫外谷胱甘肽浓度,而无效化合物显示出最低的浓度。
与各自的对照组相比,2(R,S)-甲基噻唑烷-4(R)-羧酸、2(R,S)-正丙基噻唑烷-4(R)-羧酸和N-乙酰-L-半胱氨酸是仅有的在产生更高水平的紫外和放射性谷胱甘肽方面具有统计学显著意义的化合物。因此,这些前体药物具有非常有前景的抗白内障潜力。